Form 4: Medifast Director Sells Shares
Insider Transaction (Form 4)
Daniel R Chard, a Director of Medifast Inc, sold 19,089 shares of common stock on September 28, 2026.
Summary
- Open-market sale: disposed of 9,545 Common Stock at $11.98 ($114,338) on September 28, 2026; holds 140,153 after (Indirect).
- Open-market sale: disposed of 9,544 Common Stock at $11.73 ($111,951) on September 29, 2026; holds 130,609 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $226,289 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Daniel R Chard — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-28 | Open-market sale | Common Stock | 9,545 | $12 | $114.3K | 140,153.352 |
| 2026-09-29 | Open-market sale | Common Stock | 9,544 | $12 | $112.0K | 130,609.352 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-28 | Open-market sale (9,545 shares) |
| 2026-09-29 | Open-market sale (9,544 shares) |
Keywords
insider transaction, Form 4, MED, MEDIFAST INC, bearish, Daniel R Chard
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.